Welcome to International Network for Natural Sciences | INNSpub

Assessment of clinical complications associated with diabetes mellitus type-2 in patients reporting to Mardan Medical Complex (MMC)

Research Paper | March 1, 2018

| Download 4

Dr. Atif kamil, Muneeb Ahmad, Ivar Hordvik

Key Words:

Int. J. Biosci.12( 3), 218-223, March 2018

DOI: http://dx.doi.org/10.12692/ijb/12.3.218-223


IJB 2018 [Generate Certificate]


The disease of diabetes mellitus type-2 has been characterized as long-term metabolic disorder with high blood sugar level, insulin resistance, and insufficient amount of insulin. The most common clinical symptoms are increased hunger and thirst, feeling tired, frequent urination and excessive weight loss. It is the most common non-communicable disease of the modern world, affecting 200 million people worldwide and causes an estimated 32 million deaths every year. Its prevalence has risen exponentially around the globe in the last few decades. The most common complication arise with time in diabetic patients are hypertension, retinopathy, neuropathy, Obesity, diabetic foots and nephropathy. In the current study the reported cases of diabetic mellitus type-2, at Mardan Medical Complex (MMC), were observed for the development of the aforementioned complications. In the study period of two months, March and April 2016, 163 patients suffering from diabetes Mellitus type-2 disease (including 89 female patients and 74 male patients) visited MMC were included for assessment. The most common and highly developed complication found in around 72% diabetic patients was hypertension. The other complications found were retinopathy in around 65%, diabetic foot in around 20%, and neuropathy in around 18% and nephropathy in around 12% patients suffering from diabetes Mellitus type-2 disease.


Copyright © 2018
By Authors and International Network for
Natural Sciences (INNSPUB)
This article is published under the terms of the Creative
Commons Attribution Liscense 4.0

Assessment of clinical complications associated with diabetes mellitus type-2 in patients reporting to Mardan Medical Complex (MMC)

The National Diabetes Services Scheme is an initiative of the Australian Government administered with assistance of Diabetes. www.diabetesau stralia.com.au/type-2-diabetes

Diabetes. 2017. Diabetes Digital Media Ltd – the global diabetes community. www.diabetes. co.uk/type2-diabetes.html

U.S. Department of Health and Human Services National Institutes of Health. https://medlineplus. gov/diabetestype2.html

American diabetes association, the diabetes advisor. https://professional.diabetes.org/sites/professional.diabetes.org/files/media/Mayo Foundation for Medical Education and Research (MFMER). www.mayoclinic.org/diseases-conditions/type-2-diabetes/diagnosis-treatment.

American diabetes association.  www.diabetes. org/living-with-diabetes/complications/Macro vascular and micro vascular complications of diabetes.

Micheal J, fowler MD. 2008. Clinical Diabetes Volume 26, Number 2, 2008 Medline plus trusted health information. www.medlineplus.gov/ diabeticfoot.html

Diabetic foot primary care assessment and monitoring. www.bmj.com/content/359.

National institute of health America (NIH). https:// nei.nih.gov/health/diabetic/retinopathy

Newman and Taub Vision Center and MedNet Technologies, Inc.  www.eyesurgeonsdallas. com/eye-conditions

International Journal of Nephrology and Reno vascular Disease. www.ncbi.nlm.nih.gov/ pmc/articles/PMC4206379/

What is diabetic nephropathy? By Tom Seymour. https://www.medicalnewstoday.com/articles/319686

Global report on diabetes world health organization. isbn9789241565257. http://apps.who.int/ bitstream/ 10665/204871/1/9789241565257_eng.pdf?ua=1&utm_source=blog&utm_campaign=rc_blogpost

International Diabetes Federation.  www.idf.org/our-network/regions-members/middle-east-and-north-africa/members/ 43-pakistan.html

Powers AC. Diabetes mellitus. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, et al, editors. 2008. Harrison’s Principles of Internal Medicine. 17th Ed. New York: The McGraw-Hill p.2276-92.

Shaw JE, Sicree RA, Zimmet PZ. 2010. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract  87(1), 4-14.

Basit A, Williams R. 2006. Promoting care in underserved communities: launching World Diabetes Day in Karachi. Diabetes Voice 51(2), 46-7.

Shera AS, Rafique G, Khuwaja IA, Baqai S, Khan IA, King H. 1999. Pakistan National Diabetes Survey. Prevalence of glucose intolerance and associated factors in North West at Frontier Province (NWFP) of Pakistan. J Pak Med Assoc 49(9), 206-11.

Shera AS, Rafique G, Khuwaja IA, Baqai S, King H. 1999. Pakistan National Diabetes Survey. revalence of glucose intolerance and associated factors in Baluchistan province. Diabetes Res Clin Pract 4(1), 49-58.

Definition,classification and diagnosis of diabetes, pre diabetes and metabolic syndrome. Canadian Journal of Diabetes Journal Homepage: www.canadianjour nalofdiabetes.com

Gulabani M, John M, Isaac R. 2008. Knowledge of Diabetes, its Treatment and Complications Among Diabetic Patients in a Tertiary Care Hospital. Indian J Community Med 33(3), 204-6.

Comparative analysis of associated complications of diabetic type-2 hamzullah khan department of community medicines, Khyber medical college Peshawar.

Schuster DP, duvuui. Diabetes mellitus. 2002. Clin pediatr Med surg 19, 79-107.

American diabetes association. 1995. Diabetes and exercise: the risk benefits profile. In devlin jt, ruderman N, Alexander VA. Guide to diabetes and exercise 3-4.

Type 2 diabetes mellitus updated. Dec 12 2017 author; Romesh Khardori, MD, PhD, FACP; Chief Editor: George T Griffing, MD